ReviewJournal of hypertension2017
Rationale for nebivolol/valsartan combination for hypertension: review of preclinical and clinical data.
Thomas D Giles et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
7 papers cite it
this paperpooled itcites it